All posts by imreal

Society: Disabled Issues / Disabilities

The Exceptional Women Alliance (EWA) announces the selection of Regine Lawton, executive advisor

Leave a comment


“Regine is passionate about digital innovation with a rich background in business management and sought-after expertise in emerging technologies,” said Larraine Segil, Chair & CEO of EWA. “Her global perspective and powerful leadership style are an asset to our growing network of women, and we are thrilled to welcome Regine to EWA!”

“I am so grateful for being an EWA awardee and now advisory board member to continue to reach and enable women growth and successes in our ever-changing technology world. These core critical values – adaptability and innovation with a humanistic leadership approach, continue to emerge as lifelines to effectively grow and secure businesses,” said Regine Lawton.

Ms. Lawton is an experienced board director and executive advisor. She advises on global strategies, M&A growth, and has led over 10 transactions in the past seven years with various PE firms.

The Exceptional Women Alliance (EWA) is an invitation only peer mentorship organization where high-potential, high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed. In addition to the achievement of significant success, the criteria for acceptance include character traits that are defining of the EWA Culture – Kindness, the Spirit of Generosity, Transparency, Gratitude and Willingness to Share their Networks. The Foundation is a powerhouse of peer-to-peer mentoring that provides guidance, deep connection, and leadership, propelling each woman to sustainable success – one woman at a time. The year-long program enables each member to be connected as alumnae for life in the ever-expanding EWA global network, as their fellow women leaders continue to move into positions of significance. Learn more at https://www.exceptionalwomenalliance.com/
Follow us on Facebook

Media Contact

Larraine Segil, Exceptional Women Alliance, 3106781499, [email protected], www.exceptionalwomenalliance.com

SOURCE Exceptional Women Alliance

Health

Batshaw Foundation Names Ayisha Issa First-Ever Ambassador

Leave a comment


Star of CTV’s Transplant experienced challenging adolescence and directly benefited from Batshaw’s services

MONTREAL, Nov. 14, 2023 /PRNewswire-PRWeb/ — The Batshaw Youth and Family Centres Foundation (Batshaw Foundation), which provides direct support to clients of Batshaw Youth and Family Centres (Batshaw), today named Canadian television and film actor Ayisha Issa as its first-ever Ambassador.

Born in Montreal, Ayisha is celebrated for her roles in English- and French-language television series and films, including her portrayal of Dr. June Curtis in Transplant, the CTV medical drama now in its fourth season. Last year, she won the ‘Canadian Screen Award’ for ‘Best Supporting Actor in a Drama Series’ for this role.

Ayisha faced challenges in her adolescence and consequently experienced Batshaw’s services firsthand. Determined and resilient, Ayisha got into sports, continued her studies and found a way through a very difficult time. Today, Ayisha is a passionate advocate for youth in-care and children at-risk. She understands the importance of empowering and nurturing these young individuals. Her unique life experience illustrates the remarkable outcomes that may occur when youths facing adversity are given the necessary tools and support to overcome major obstacles.

As Batshaw Foundation Ambassador, Ayisha is committed to helping vulnerable youth reach their full potential. Through advocacy, outreach and collaboration, Ayisha will play a vital role in helping break the stigma of being a former youth in care. She will also increase awareness of the Batshaw Foundation’s ongoing work and success in support of children, youth and families. Additionally, Ayisha will join Batshaw’s Youth Advisory Council, where she will serve as an advocate for Batshaw clients.

“We are delighted to welcome Ayisha to the Batshaw Foundation,” says Wendy Khan, Executive Director, Batshaw Foundation. “Her extraordinary journey, commitment, perseverance and vision make her a uniquely qualified advocate for at-risk youth. Ayisha is an inspiration to everyone at Batshaw.”

“I am honoured to be joining the Batshaw Foundation,” adds Ayisha Issa. “As Ambassador, I would like to tell vulnerable youth that hope and resilience – combined with the right support – can change lives. I understand this because I am living proof that bright and promising futures are real possibilities.”

Notes to Editors

About the Batshaw Foundation

The Batshaw Youth and Family Centres Foundation (Batshaw Foundation) is a charitable organization whose mission is to empower the vulnerable children, youth and families served by youth protection and other services for youth in difficulty, by providing them with funding, tools and opportunities so that they can unlock their potential and achieve success — now and into the future. Founded in 1978, the Batshaw Foundation has a long history of providing financial support, where public funds are not available, to those served by the Batshaw Youth and Family Centres. Through various fundraising initiatives and the generosity of its community, the Batshaw Foundation funds programs in the following areas: family emergency and prevention, well-being, education and employability, and aging out of care. To learn more about the Batshaw Foundation, please visit www.batshawfoundation.ca

Media Contact

Mark Lowe, PRagmatic Communications

mark.lowe(at)pragcom.com / (514) 576-2519

Media Contact

Mark Lowe, Batshaw Foundation, 1 (514) 576-2519, [email protected], https://www.batshawfoundation.ca/

SOURCE Batshaw Foundation

Health

Intelerad to Reveal Product Enhancements at RSNA, Unifying Imaging Data Across Health Systems

Leave a comment


As part of the ongoing efforts to seamlessly connect their product lines, Intelerad is also focused on unifying the Life Image and Ambra platforms to enhance access to the world’s largest image exchange network, created last year with Intelerad’s acquisition of Life Image. Life Image clients will be able to natively connect with Ambra clients and vice versa, offering a smooth, uninterrupted exchange experience that encourages true collaboration and optimal patient outcomes.

Intelerad will also offer RSNA attendees a more in-depth look at its AI-enhanced solutions, which offer the best of both worlds – access to regulatory-approved AI algorithms and the flexibility to choose an AI vendor without being concerned about compatibility. Intelerad vendor-neutral solutions provide clients with workflow-complementary access to a wide and growing range of advanced AI algorithms.

Intelerad’s solutions integrate and interface seamlessly with clients’ preferred AI solutions. For example, Clario SmartWorklist can now intelligently drive which cases should be sent to AI Platform based on defined criteria. Following recent enhancements, customers can also more easily define how AI results will impact the worklist prioritization.

Intelerad’s newly enhanced streaming capabilities will also be on display at its RSNA booth # 6104. Clients can now stream images from the Intelerad Cloud Long-term Archive at speeds comparable to those from on-premise PACS. Organizations get the superior scalability, security and cost-savings synonymous with cloud hosting and paired with the fastest streaming available, eliminating the need to choose one set of benefits over the other.

“Intelerad’s platform is the backbone of our clients’ imaging strategies, and at RSNA 2023, we’ll share more about our ongoing efforts to unify our solutions, connecting with EHRs throughout the ecosystem and expediting the delivery of improved patient care,” Intelerad President Morris Panner said. “We look forward to connecting with colleagues and peers to discuss product innovation, medical imaging developments and initiatives for improving the overall patient experience.”

To learn more about Intelerad’s portfolio of fully integrated solutions and the company’s commitment to providing innovative technologies, book a demo with the team today. To request a media briefing with Intelerad at RSNA 2023, please email [email protected].

About Intelerad
Intelerad is one of the leading providers of medical imaging software and services for the healthcare industry. Headquartered in Raleigh, NC and Montreal, Quebec, Intelerad has over 900 employees located in offices across six countries. Nearly 2,500 healthcare organizations around the world rely on Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad’s award-winning enterprise imaging solutions have been recognized globally by KLAS, with Intelerad’s Image Exchange ranked #1 for eight consecutive years. To learn more, visit intelerad.com.

Media Contact

Hollie Barnidge, Alloy on behalf of Intelerad, 855-300-8209, [email protected], https://www.intelerad.com/en/

SOURCE Intelerad

health and fitness

Memorial Neuroscience Institute Performs Livestreamed Brain Aneurysm Procedure

Leave a comment


“Memorial’s Neuroscience Institute is one of the first pilot sites selected by the Society of Vascular and Interventional Neurology (SVIN) for a global tele-observership program using virtual proctoring software such as Proximie,” said Dr. Mehta. “It’s an innovative technology that has the potential to train physicians around the world, especially in developing countries, on the latest stroke treatments and neurointerventional techniques.”

Drs. Mehta and Delgado utilized a minimally-invasive, endovascular treatment on Stephane Desjardins to treat the brain aneurysm, one that had a high probability of being fatal if it had ruptured and bled in the brain. The catheter-based image navigation procedure enabled the placement of the WEB device to secure the aneurysm. The procedure was a success due to the real-time virtual proctoring made possible with the Proximie system.

Approximately 30,000 people in the United States suffer a brain aneurysm rupture each
year, according to the Brain Aneurysm Foundation.

“I had worsening headaches, was dizzy, nauseous, and had no energy,” said Desjardins, whose aneurysm was discovered during a CT scan when he presented to the Memorial Regional Hospital emergency room. “Dr. Mehta got me in right away and I’ve haven’t had any issues since the procedure.”

The 53-year-old Desjardins was discharged from the hospital a day after the cutting-edge surgery without any neurological impairments and returned to a meaningful quality of life with his family.

Memorial Neuroscience Institute offers advanced diagnoses, comprehensive treatment, compassionate care, and rehabilitation for complex neurological conditions. Few centers can match the depth of its neurological expertise or the wide range of available services.

Part of the Memorial Healthcare System and recognized for its quality and safety, the institute treats conditions of the brain that include Alzheimer’s and Parkinson’s disease, multiple sclerosis, tumors, epilepsy, stroke, and subarachnoid hemorrhages, as well as issues of the neck, back, and spine.

To learn more about the complete continuum of neurological care Memorial provides, visit http://www.mhs.net/neuroscience.

Media Contact

Yanet Obarrio Sanchez, Memorial Healthcare System, 954-265-1136, [email protected], www.mhs.net 

SOURCE Memorial Healthcare System

Home and Family: Marriage / Relationships

Beagle Scout Snoopy and the YMCA Team Up to Help Kids Celebrate Summer

Leave a comment


Healthy Kids Day® Sponsorship (U.S. only): In 2024 and 2025, Peanuts will be the national sponsor for Healthy Kids Day, the Y’s national initiative to improve the health and well-being of kids and families. Reaching more than 1 million attendees across 1,450 free community events, Ys across the country aim to inspire kids and families to keep their minds and bodies active throughout the summer months.

National and International Y Camp Scholarships (overnight and day camps): Peanuts will provide 1,800 camp scholarships over three years, offering a transformational camp experience to kids who may not otherwise be able to participate. Peanuts also will collaborate on Beagle Scout conservation programs with National Parks Service Y camps, providing engaging age-appropriate Peanuts materials and activities for children. In addition, Peanuts will provide 500 camp scholarships across Y camp locations in Germany, Spain, Korea and Japan over three years, including translated Peanuts materials and communications.

“As we mark 50 years of the beloved Beagle Scouts, we celebrate the kind of outdoor adventures that pop up throughout the Peanuts comic strip—healthy and fun-filled activities that every child should have access to,” says Melissa Menta, Senior Vice President, Marketing and Communications for Peanuts Worldwide. “It makes perfect sense to partner with an organization that is synonymous with making camp accessible for all: the Y. We’re excited to work together to bring great outdoor adventures to children in five different countries!”

“Children have a natural fondness for Snoopy, so we’re delighted that Beagle Scout Snoopy and his fellow scouts will be working with the Y to engage kids in great summertime activities,” says Abby Rogers, Executive Vice President and Chief Development Officer for Y-USA. “We believe camp is a transformational experience, and Snoopy and Peanuts will be making a huge difference in kids’ lives as they make new friends, learn new skills, and interact with nature.”

About Peanuts
The characters of Peanuts and related intellectual property are owned by Peanuts Worldwide, which is 41% owned by WildBrain Ltd. (TSX:WILD), 39% owned by Sony Music Entertainment (Japan) Inc., and 20% owned by the family of Charles M. Schulz, who first introduced the world to Peanuts in 1950, when the comic strip debuted in seven newspapers. Since then, Charlie Brown, Snoopy and the rest of the Peanuts gang have made an indelible mark on popular culture. In addition to enjoying beloved Peanuts shows and specials on Apple TV+, fans of all ages celebrate the Peanuts brand worldwide through thousands of consumer products, as well as amusement park attractions, cultural events, social media, and comic strips available in all formats, from traditional to digital.

About the Y
Driven by its founding mission, the Y has served as a leading nonprofit committed to strengthening community for more than 175 years. The Y empowers everyone, no matter who they are or where they’re from, by ensuring access to resources, relationships, and opportunities for all to learn, grow and thrive. By bringing together people from different backgrounds, perspectives and generations, the Y’s goal is to improve overall health and well-being, ignite youth empowerment and demonstrate the importance of connections in and across 10,000 communities nationwide. Learn more at ymca.org.

Media Contact

Ashley Shewey, YMCA of the USA, 3124160870, [email protected], https://www.ymca.org/

SOURCE YMCA of the USA

Health: Psychology

VGXI Celebrates Successful Completion of Neurophth Engineering Run to Advance Ocular Gene Therapy Candidate

Leave a comment


VGXI, Inc. proudly announces the successful completion of the engineering run for plasmid DNA used in Neurophth’s AAV ocular gene therapy.

CONROE, Texas , Nov. 14, 2023 /PRNewswire-PRWeb/ — VGXI, Inc., a leading contract development and manufacturing organization (CDMO) specializing in nucleic acid biopharmaceuticals, including gene therapies and DNA vaccines, proudly announces the successful completion of the engineering run for plasmid DNA used in Neurophth’s AAV ocular gene therapy candidate, NFS-01.

Neurophth, China’s leading clinical-stage, in-vivo gene therapy company dedicated to combatting opthalmic diseases, has collaborated closely with VGXI since 2020. VGXI played a pivotal role in the development of NFS-01, by supplying all three essential plasmid constructs to formulate the AAV candidate. Neurophth selected VGXI as a manufacturing partner to expand U.S.-based manufacturing in support of ongoing clinical production. VGXI’s achievements include the generation of GMP Master Cell Banks (MCBs) and a seamless transition into Good Manufacturing Practice (GMP) bulk plasmid manufacturing.

NFS-01 is China’s first self-developed AAV-based gene therapy to treat Leber hereditary optic neuropathy caused by ND4 mutation (ND4-LHON), a condition currently lacking an effective treatment or cure. It was granted orphan drug designation by the FDA and EMA. It received China IND clearance from the NMPA in March 2021‥and U.S. IND clearance from the FDA in January 2022. Neurophth has completed patient enrollment for the Phase III clinical trial and announced positive data from the Phase I/II clinical trial in China recently. Meanwhile, the first patient has been dosed in the international multi-region, multi-center Phase I/II clinical trial in the U.S.

In addition to NFS-01, Neurophth successfully administered the first dose of NFS-02 to patients in August 2023 as part of an international multi-region, multi-center Phase I/II clinical trial. This trial aims to treat Leber hereditary optic neuropathy caused by ND1 mutation (ND1-LHON), another condition currently lacking an effective treatment or cure. This product is Neurophth’s second gene therapy to enter clinical trials and the only ND1-LHON treatment in development worldwide. The material produced by VGXI will not only be integral to the ongoing clinical trial but will also provide crucial support for late-stage testing and eventual commercialization upon regulatory approval.

The progress made thus far exemplifies the dedication and expertise of both Neuropthth and VGXI in advancing groundbreaking gene therapies.

“We are thrilled to have partnered with Neurophth in their journey towards bringing innovative ocular gene therapies to patients worldwide,” stated Young Park, CEO of VGXI. “This successful engineering run is a testament to the collaborative efforts of our teams and the commitment to excellence that drives our work. We look forward to continuing our partnership and remain dedicated to supporting Neurophth as they continue their pursuit of commercial approval for their AAV ocular gene therapy.”

“Thank you to VGXI’s cutting-edge plasmid DNA platform. Our new drug development and clinical trials are progressing smoothly.” said Bose Kalampanayil, CTO of Neurophth. “It is a significant step toward addressing unmet medical needs in ocular diseases. We eagerly anticipate further collaboration in expediting the commercial manufacturing of our gene therapy, delivering safe and effective treatments to patients worldwide.”

ABOUT VGXI, INC.

VGXI is a leader in plasmid DNA contract manufacturing, with 20+ years of experience providing high quality products to biomedical researchers worldwide. We support clients that develop DNA vaccines, immunotherapies, cell therapies, and gene therapies. VGXI’s manufacturing process and quality controls are coupled to a continuous, low-shear AIRMIX® patented lysis technology, and optimized purification processes that provide highly supercoiled plasmid and exceptional purity. VGXI’s portfolio includes high quality plasmid for preclinical research, Highly Documented (HD) plasmid as a critical raw material for GMP viral vector production or pharm/tox studies, cGMP plasmid DNA for clinical through commercial supply, and custom services. VGXI, Inc. is a GeneOne company.‥To learn more, visit‥https://www.vgxii.com.

ABOUT NEUROPHTH.

Neurophth is China‘ leading in-vivo gene therapy company for ophthalmic diseases. With subsidiaries in China (Wuhan, Shanghai, and Suzhou) and US (San Diego, California), Neurophth, a fully integrated company, is striving to discover and develop genomic medicines for patients suffering from genetic diseases globally. Our validated AAV platform, which has been published in‥Nature – Scientific Reports, Ophthalmology, and EBioMedicine, has successfully delivered proof-of-concept investigator-initiated trials data of 186 subjects with investigational gene therapies in the retina. Our most advanced investigational gene therapy drug candidate, NFS-01 (rAAV2-ND4), in development for the treatment of mtND4-mediated LHON, has been granted orphan drug designation (ODD) by the U.S. FDA and EMA. After the IND clearance by the China NMPA in March 2021‥and the U.S. IND by FDA in January 2022, Neurophth has completed patient enrollment for Phase III clinical trial in China and dosed the patient in the U.S. Phase I/II clinical trial. Recently, our second gene therapy NFS-02, has dosed the patient in China-U.S. Phase I/II clinical trial. The pipeline also includes autosomal dominant optic atrophy, optic neuroprotection, vascular retinopathy, and five other preclinical candidates. To learn more about us and our growing pipeline, visit http://www.neurophth.com.

Media Contact

Justin Smith, Director of Marketing, VGXI, (936) 304-2333, [email protected], vgxii.com

SOURCE VGXI

Health

#ThxBirthControl Campaign Continues to Empower and Inform Amidst Challenges in Reproductive Health

Leave a comment


“Thanks, Birth Control is a movement that’s needed now more than ever,” said Power to Decide’s CEO, Dr. Raegan McDonald-Mosley. “In the wake of the Dobbs decision, as abortion is banned or restricted in half the U.S. and birth control access and sex education are under attack everywhere, young people are telling us that they do not have the birth control information they want and need. By sharing so many stories – proudly and publicly – about all that birth control makes possible, #ThxBirthControl combats shame and stigma and brings birth control information directly to young people where they are – on social media. Today is a kick-off, not a one-off. We will continue to shine the national spotlight on the importance of birth control access for all and we encourage everyone to say Thanks, Birth Control with us.”

Power to Decide has released its annual survey findings ahead of this year’s #ThxBirthControl campaign. The survey, conducted among 1,150 individuals aged 15-29, assigned female at birth, sheds light on young people’s access to quality information about birth control in 2023.

Here are some key findings from the survey:

Lack of Information: Over one-third (34.5%) of young people aged 15-29 have not received information about birth control in the past 12 months. (Power to Decide, 2023)

Concerns about the Safety of Hormonal Birth Control: 28% of all respondents disagree or strongly disagree that hormonal birth control is safe. (Power to Decide, 2023)

Influence of Social Media: 25% of 20-29-year-olds received information about birth control from social media in the last year. (Power to Decide, 2023)

Disconnect Between Actual and Preferred Sources of Information: While 86% of 20-29-year-olds want to receive birth control information from health care providers, less than 47% actually did in the past year. (Power to Decide, 2023)

Information Gap for Teens: 24% of 15-19-year-olds feel they lack enough information to make decisions about the birth control method that is best for them. (Power to Decide, 2023)

Benefits Outweigh Side Effects: Despite concerns about the safety of hormonal birth control, nearly three-quarters (74%) of respondents believe that the benefits of birth control outweigh the side effects. (Power to Decide, 2023)

Implications and Recommendations:

1. Social Media Education: The survey highlights the role of social media in providing young people with information about birth control. As misinformation looms, there is a growing need for accurate and educational birth control content on platforms like Instagram and TikTok.

2. Strengthening Patient-Provider Communication: The disconnect between what young people want and what they receive from health care providers underscores the urgent need for improved communication. In a post-Roe era, where access to contraception is paramount, building trust and ensuring access to accurate information becomes even more crucial.

3. Harnessing Social Media for Health Care Providers: Recognizing the power of social media, health care providers are encouraged to provide trusted, high-quality information through platforms like Instagram and TikTok. Dr. Raegan McDonald-Mosley, CEO of Power to Decide, leads by example with her viral Ask Dr. Raegan series on TikTok.

#ThxBirthControl Day Ahead:

As #ThxBirthControl Day approaches on November 15, this year’s campaign aims to amplify the voices of those impacted by the issues revealed in the survey. The 2023 Thanks Birth Control Survey serves as a vital resource for understanding the current state of young people’s experiences with birth control information and services in the U.S., especially during a critical time for reproductive health care access.

For further information, interviews, or collaboration opportunities, please contact Chelsea Leibow, Chelsea Leibow Communications ([email protected]).

About Power to Decide
Power to Decide is a nonprofit, nonpartisan organization that works to advance sexual and reproductive well-being for all by providing trusted information, expanding access to quality services, and catalyzing culture change.

About the Survey:
This study was conducted for Power to Decide using Ipsos probability-based online panel, KnowledgePanel. Data were collected from September 29, 2023 – October 6, 2023 among individuals 15 to 29 years of age, assigned female at birth. A total of 1,150 surveys were completed with a margin of error for total respondents of +/- 3.5 percentage points adjusted for design effect, at the 95% confidence level.

Power to Decide would like to thank the following partners for their support and commitment to contraceptive access: Bayer Pharmaceuticals and JPB Foundation.

Media Contact

Chelsea Leibow, Power to Decide, 925-209-9838, [email protected], powertodecide.org

SOURCE Power to Decide

Health: Mental Health

Vitenas Cosmetic Surgery Earns Over 800 Google Reviews

Leave a comment


Houston’s renowned Vitenas Cosmetic Surgery has achieved a significant milestone, earning over 800 Google reviews from satisfied patients. This accomplishment spotlights the Dr. Vitenas’s commitment to excellence and high-quality patient care.

HOUSTON, Nov. 14, 2023 /PRNewswire-PRWeb/ — Over 800 Google Reviews for Vitenas Cosmetic Surgery

Since 1990, Dr. Vitenas’s leadership, patient care, and proven results have led to the notable accumulation of over 800 Google reviews.

The Vitenas Cosmetic Surgery team’s reputable number of glowing Google reviews is a testament to the quality of their services, the dedication of their staff, and their commitment to patient satisfaction. These reviews reflect the trust and confidence placed in them by patients who have chosen Vitenas Cosmetic Surgery for their cosmetic and plastic surgery needs.

Why Patient Reviews Matter in Cosmetic Surgery

In the cosmetic surgery industry, patient reviews play a pivotal role. They offer potential patients a glimpse into the real-life experiences of those who have undergone various plastic surgery procedures.

These reviews provide invaluable insights into the quality of care, professionalism, and results delivered by board-certified plastic surgeons like Dr. Paul Vitenas. Whether it’s a mommy makeover, breast lift, or facial surgery, the reviews highlight the practice’s ability to deliver natural-looking results and compassionate care. They also underscore the expertise of Dr. Vitenas as a plastic surgeon and his innovative approach to cosmetic surgery.

The surplus of over 800 Google reviews earned by Vitenas Cosmetic Surgery exemplifies their consistent delivery of high-quality care, commitment to patient satisfaction, and positive experiences. Patients who choose Vitenas Cosmetic Surgery trust and have confidence in their services, as reflected in the reviews.

More About Vitenas Cosmetic Surgery

Founded by Dr. Paul Vitenas, Vitenas Cosmetic Surgery is a renowned medical practice for cosmetic enhancements in Houston, Texas. The practice offers a wide range of cosmetic and plastic surgery procedures, such as breast augmentation, tummy tucks, facial rejuvenation, reconstructive surgery, and more. With a focus on natural-looking results and compassionate care, Vitenas Cosmetic Surgery intends to enhance each patient’s unique beauty.

Vitenas Cosmetic Surgery is proud to have its facility conveniently situated between Greenway Plaza and The Galleria, in its new state-of-the-art building.

The center is accredited by the American Association for Accreditation of Ambulatory Surgical Facilities (AAAASF), which ensures that they offer the best quality of care to their patients in a secure and trustworthy environment.

Who is Dr. Paul Vitenas?

Dr. Paul Vitenas is certified by the American Board of Plastic Surgery and has more than three decades of experience in cosmetic surgery. He graduated from Tulane University Medical School and completed multiple residencies and fellowships in Maxillofacial, Craniofacial, and Cosmetic Surgery. Dr. Vitenas is known for his innovative techniques and has received numerous awards for his contributions to the field of cosmetic surgery.

In addition, Dr. Paul Vitenas is a highly decorated plastic surgeon with academic achievements and memberships in top medical societies. However, he cherishes the awards he has received directly from his patients the most. These accolades include Multiple Patient’s Choice Awards, recognition as one of America’s Most Compassionate Doctors, and the Named the Best Facial Plastic Surgeon in Houston in 2022 by Houstonia Magazine.

Dr. Vitenas has also received several prestigious recognitions in his career, such as being named the Best Single Physician Practice, a Top Ten Plastic Surgeon in Middle America, a Texas Super Doctor, a Top Doctor on RealSelf, and the recipient of an Angie’s List Super Service Award.

These accomplishments are a testament to his expertise, innovation, and dedication to the field of cosmetic surgery.

Dr. Vitenas’s Approach to Cosmetic Surgery

Dr. Vitenas’s approach to cosmetic surgery is centered on accentuating each patient’s natural features. He believes in delivering personalized care, starting from the initial consultation through the entire patient journey. His focus on patient experience and satisfaction is reflected in the high Google reviews received by his practice.

Vitenas Cosmetic Surgery’s Community Involvement

Vitenas Cosmetic Surgery takes great pride in being an active member of the Houston community. Giving back to the community is an essential part of their mission and values. Dr. Vitenas collaborates with several local and national charities and partners with numerous small businesses in Houston as a way to support and give back to the community. They believe that the practice has thrived due to its deep connection to the wonderful city of Houston.

The Patient Journey at Vitenas Cosmetic Surgery

From the very first phone call, the patient journey at Vitenas Cosmetic Surgery is designed to be a seamless and comfortable experience. The dedicated team at the practice, led by Dr. Vitenas, works tirelessly to ensure each patient is treated with the utmost care and attention.

Upon arrival, patients are greeted by a friendly patient coordinator who guides them through the initial consultation process. Dr. Vitenas then personally meets with each patient to discuss their aesthetic goals and concerns, providing professional advice on the best plastic surgery procedures to achieve the desired results.

Throughout the process, Dr. Vitenas and his team maintain regular follow-ups with the patients, ensuring they feel supported and well-informed at every stage. The practice prides itself on its commitment to delivering outstanding results and a wonderful patient experience.

Contact Vitenas Cosmetic Surgery Today

For those considering cosmetic surgery and looking for a highly recommended, experienced, and compassionate team, Vitenas Cosmetic Surgery is the ideal choice.

To learn more about the services offered or to schedule a consultation, contact the practice today.

Cosmetic surgery can make a dramatic difference in one’s appearance and self-confidence when performed by a reputable, experienced surgical team. Let Vitenas Cosmetic Surgery help you look and feel your best. With over 800 positive Google reviews, you can trust that you’re in good hands.

Media Contact

Amelia Viera, Vitenas Cosmetic Surgery, 281-484-0088, [email protected], drvitenas.com

SOURCE Vitenas Cosmetic Surgery

Lifestyle: Self Help

PI Establishes Innovation Hub to Strengthen Collaboration with Technical Research Institutes

Leave a comment


While companies typically emphasize product and production-related R&D, the research clusters are dedicated to future and post-future topics. “We aim to continue to be leaders in our competency areas three, five, and more years from now. The innovation hubs are a crucial component along this journey,” asserts Spanner.

Industries Served
Industrial Automation, Semiconductor Manufacturing, Automotive, Silicon Photonics, Quantum Computing, High Resolution Microscopy, Life Sciences

Learn more

PI Americas
http://www.pi-usa.us | [email protected] | (508) 832-3456

Applications Blog | Videos | X | LinkedIn

Media Contact

New Innovation Hub, PI (Physik Instrumente) LP, (508) 832-3456, [email protected], https://www.pi-usa.us

SOURCE PI (Physik Instrumente) LP



Legal / Law: Criminal Law

Webinar to Share Best Practices on Growing A Business with UPC Barcodes from GS1 US

Leave a comment


Virtual Event to Highlight How Businesses Can Take Advantage of Barcoding Basics to Break Into Retail

EWING, N.J., Nov. 14, 2023 /PRNewswire-PRWeb/ — GS1 US and Startup CPG will host a free webinar designed to help businesses understand supply chain fundamentals and be prepared to meet retailer labeling requirements.

Webinar: “Product Identification 101: How UPC Barcodes from GS1 Lead to Growth”

  • WHAT: A one-hour educational session that will showcase practical tips and expert knowledge, focused on leveraging GS1 Standards to grow a business.
  • WHEN: November 16, 2023, from 5:00PM – 6:00PM ET
  • REGISTER: https://www.eventbrite.com/e/product-identification-101-how-upc-barcodes-from-gs1-lead-to-growth-tickets-740588198237?aff=odcleoeventsincollection
  • SPEAKER INFORMATION: This free, virtual event will feature tips from Kaitlin Friedmann, marketing director, small business growth, GS1 US. Kaitlin collaborates with members of the small business community to enrich their understanding of barcodes and the value of GS1 product identification. She helps entrepreneurs fuel their own success by developing content, tools and experiences on topics including product launches, e-commerce, supply chain optimization, and working with retailers.

This webinar will show attendees the role of the Global Trade Item Number (GTIN) and the UPC barcode in inventory management, retailer verification processes, and the tracking and tracing of products. Other areas that will be discussed include:

  • How to estimate how many barcodes a business might need.
  • Understanding packaging hierarchies, such as the difference between an “each” and an “inner pack.”
  • How to know when a new GTIN is needed.
  • Common types of barcodes and how they are evolving to meet consumer expectations.

About GS1 US 
GS1 US® enables companies to power their supply chains to deliver safe, consistent, authentic, and trusted experiences. Best known as a source for UPC barcodes, GS1 is a not-for-profit, global data standards organization that creates a common language for companies to identify, capture and share trusted data that links their physical and digital supply chains. Millions of businesses around the world power commerce with GS1 Standards. Learn more at http://www.gs1us.org.

Media Contact

John Gramuglia, GS1 US, 5512065530, [email protected]

SOURCE GS1 US